Acne Face Mapping: Can the Location of Your Breakouts Explain Their Cause?
Months of recurring acne in the same spot on my face and one panicked Google search later, I landed upon face mapping—i.e., a ...
How a healthy skin microbiome protects against chronic health issues
A healthy skin microbiome plays a crucial role in regulating our immune system and preventing chronic health issues, such as ...
Hosted on MSN2d
What Is Perioral Dermatitis? 2 Dermatologists Explain
Skin conditions are more common than you might think, with perioral dermatitis being one of the most prevalent. You've likely ...
Cosmetic fillers are popular but come with risks. Here's what to know from a dermatologist.
Despite the popularity of cosmetic filler injections, these procedures can carry some risks​. Here's what an expert says ...
Medscape3d
‘Round Face’: A Viral Term’s Real Diagnostic Implications
Popular videos and social media posts have identified cortisol as the main culprit behind facial puffiness, but many ...
Scientists Unveil 16+ Distinct Nerve Cell Types Behind Human Touch
Recent research identifies 16 human nerve cell types, revealing complex sensory responses and challenging traditional views on nerve specificity. In a new study published in Nature Neuroscience, ...
thechurchnews4d
The Church advances health services in Chile and Paraguay
The Church has equipped hospitals in Paraguay and Chile with technology to enhance healthcare delivery, improve outcomes and ...
5 common skin rashes that can be caused by COVID, according to dermatologists
One specific type of viral exanthem that dermatologists have seen with COVID is a morbilliform rash, meaning a measles-like rash. Measles rashes tend to look like small raised bumps that eventually ...
ots7d
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neur
The Phase III trial AV001 aims to evaluate QUTENZA® in post- surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after ...
Grünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA
The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...